| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/04/2002 | WO2001034099A9 Soy depigmenting and skin care compositions |
| 07/04/2002 | WO2001032189A9 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 07/04/2002 | WO2001028551A9 Agents for promoting fattening of animals and method of promoting fattening |
| 07/04/2002 | WO2001025441A3 Tumour-specific vector for gene therapy |
| 07/04/2002 | WO2001016096A3 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 07/04/2002 | WO2000074687A9 Antisense modulation of b7 protein expression |
| 07/04/2002 | WO2000073316A3 Virus immunologic determinants |
| 07/04/2002 | WO2000069900A9 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/04/2002 | WO2000069897A9 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | US20020087013 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 07/04/2002 | US20020087009 Intermediates for (r)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo[1,2-a] imidazol-2-one |
| 07/04/2002 | US20020087005 Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 07/04/2002 | US20020087002 Naphthalenyl piperidines as renin inhibitors |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 07/04/2002 | US20020086904 Methods of treating affective disorders using derivatives of (-)- venlafaxine |
| 07/04/2002 | US20020086897 Cytotoxic agents comprising taxanes and their therapeutic use |
| 07/04/2002 | US20020086884 Anticancer agents based on regulation of protein prenylation |
| 07/04/2002 | US20020086879 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 07/04/2002 | US20020086878 Monomolecular dispersions of various medicaments prepared for transmucosal delivery; treatment of respiratory illness such as cold and/or allergy |
| 07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 07/04/2002 | US20020086872 Anticoagulants; may be embedded in or physically linked to materials used in manufacture of devices used in blood collection, circulation, stents |
| 07/04/2002 | US20020086870 Pharmacological treatment for sleep apnea |
| 07/04/2002 | US20020086866 Quinoxalinones as serine protease inhibitors |
| 07/04/2002 | US20020086865 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 07/04/2002 | US20020086864 Administering optically pure (S,S) enantiomer of reboxetine |
| 07/04/2002 | US20020086862 1,2,4-triazole-3-thione compounds; treatment of disorders such as ischaemia, psoriasis |
| 07/04/2002 | US20020086859 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 07/04/2002 | US20020086858 Neuropeptide Y antagonists; treatment of eating disorders such as obesity and hyperphagia |
| 07/04/2002 | US20020086852 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 07/04/2002 | US20020086839 Inhibitors of DNA immunostimulatory sequence activity |
| 07/04/2002 | US20020086832 Immunosuppressing a human after allogenic cell, tissue or organ transplantation by administering a caspase-8 inhibitor |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086420 Novel antiangiogenic peptides |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086380 Enzymatic polypeptide for use in animal feeds and in generating chemical intermediates for vitamin A |
| 07/04/2002 | US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy |
| 07/04/2002 | US20020086342 Detection of enzyme inhibitors; obtain sample, incubate with modulator, monitor sample for dephosphorylation, compare to control |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086068 Herbal composition of blend of active components prepared from murrya koenigii and piper betle useful for blocking of 5 lipoxygenase activity leading to the inhibition of leukotriene synthesis, suppression of interleukin-4 production, and enhancement of gamma interferon release |
| 07/04/2002 | US20020086051 For delivering drug directly to interior portions of the body of a mammalian organism, such as to the eye |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086015 Compositions and methods for promoting nerve regeneration |
| 07/04/2002 | US20020085996 Can be administered before, at the same time as, or after the transplant. |
| 07/04/2002 | US20020085995 In vivo induction for enhanced function of isolated hepatocytes |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10063435A1 Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Chinazolinderviate, medicaments containing these compounds, their use and process for their preparation |
| 07/04/2002 | DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2626317A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | CA2436739A1 Combination agent |
| 07/04/2002 | CA2433520A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | CA2433220A1 Novel purine derivatives, preparation method and use as medicines |
| 07/04/2002 | CA2433116A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/04/2002 | CA2433090A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | CA2432896A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | CA2432693A1 Identification of modulators of dham-kinase and inflammatory diseases |
| 07/04/2002 | CA2432661A1 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | CA2432654A1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | CA2432570A1 New clinical treatment |
| 07/04/2002 | CA2432543A1 Combination drugs |
| 07/04/2002 | CA2432415A1 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/04/2002 | CA2432008A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 07/04/2002 | CA2431916A1 New therapeutic uses of smr1 peptides |
| 07/04/2002 | CA2431913A1 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | CA2431471A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/04/2002 | CA2430691A1 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | CA2429709A1 Motilide compounds |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219636A2 Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms |
| 07/03/2002 | EP1219632A1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 07/03/2002 | EP1219630A1 Immunopotentiating compositions |
| 07/03/2002 | EP1219619A1 Piperidine derivatives |
| 07/03/2002 | EP1219612A1 2-imino-1,3-thiazine derivatives |
| 07/03/2002 | EP1219607A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 07/03/2002 | EP1219605A1 Urea compounds, process for producing the same and use thereof |
| 07/03/2002 | EP1219601A1 Prostaglandin derivatives |
| 07/03/2002 | EP1219595A1 O-anisamide derivatives |
| 07/03/2002 | EP1219305A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/03/2002 | EP1219297A1 Antiobestic agents |
| 07/03/2002 | EP1219294A1 Melanin concentrating hormone antagonists |
| 07/03/2002 | EP1218751A2 Diagnosis of coeliac disease using a gliadin epitope |
| 07/03/2002 | EP1218747A1 Method for identifying compounds useful in the therapy of bone disorders |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218527A2 Adenoviral vectors for treating disease |
| 07/03/2002 | EP1218521A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218496A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218407A1 Uses of kappa-conotoxin pviia |
| 07/03/2002 | EP1218404A1 A binding motif of a receptor |